The most likely result for JWH 018 is that even further analysis will bring about an more potent cannabinoid.In July 2016, MDMB-CHMICA was the initial synthetic cannabinoid receptor agonist being possibility-assessed with the EMCDDA (35) and it has just lately been subjected to control steps and prison penalties in the course of Europe (36). MDMB-C